To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy Subjects
Clinical trial NCT05413161 · COMPLETED
Trial details
- NCT number
- NCT05413161
- Sponsor
- Kashiv BioSciences, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2023-02-21
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.